Related Experiment Videos
Effective formation of major histocompatibility complex class II-peptide complexes from endogenous antigen by thyroid
R Maile1, K A Elsegood, T C Harding
1Division of Medicine, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Immunology
|March 11, 2000
Summary
Thyroid epithelial cells (TECs) can present self-antigens to T cells, crucial for understanding autoimmune thyroid disease. This study shows TECs efficiently activate T cells when expressing an antigen, providing direct evidence for their antigen-presenting capability.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Thyroid epithelial cells (TECs) express MHC class II molecules, suggesting they can present self-antigens to CD4+ T cells in autoimmune thyroid disease.
- However, TECs may have limited capacity for endogenous antigen processing and presentation due to restricted MHC class II loading or expression levels.
Purpose of the Study:
- To investigate the capacity of TECs to process and present endogenous antigens in the context of MHC class II molecules.
- To determine if TECs can activate T cells when expressing an integral membrane self-antigen.
Main Methods:
- Transfection of a cloned rat TEC line (FRTL5) with an adenoviral vector expressing ovalbumin (OVA) as an integral membrane protein.
- Assessment of T-cell activation using OVA-specific, class II-restricted T-cell hybridomas.
- Evaluation of the role of MHC class II expression, induced by interferon-gamma (IFN-gamma), and blockade with anti-MHC class II antibodies.
Main Results:
- OVA-expressing FRTL5 cells efficiently activated OVA-specific T-cell hybridomas.
- The T-cell response was dependent on IFN-gamma-induced MHC class II expression and was inhibited by anti-MHC class II antibodies.
- Exogenously added OVA or OVA peptides elicited poor responses, indicating a preference for endogenous antigen presentation.
Conclusions:
- TECs can process and present endogenous antigens via MHC class II molecules to activate T cells.
- This study provides direct evidence that TECs possess sufficient capacity to form MHC class II-peptide complexes from self-antigens to trigger T-cell responses.
- These findings have significant implications for understanding the mechanisms of autoimmune thyroid diseases.